Fingerprint
Dive into the research topics of 'MPN-545 Surpass-ET: Ropeginterferon Alfa-2b (P1101) vs. Anagrelide as Second Line Therapy in Essential Thrombocythemia'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
MPN-545 Surpass-ET: Ropeginterferon Alfa-2b (P1101) vs. Anagrelide as Second Line Therapy in Essential Thrombocythemia
Ruben Mesa, Norio Komatsu, Harinder Gill, Jie Jin, Sung Eun Lee, Hsin An Hou, Toshiaki Sato, Albert Qin, Raymond Urbanski, Weichung Shih, Oleh Zagrijtschuk, Craig Zimmerman, Srdan Verstovsek
Research output: Contribution to journal › Article › peer-review